Skip to content

Author

Jiwei Zhao

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

FREM1 promotes anlotinib resistance in non-small cell lung cancer through regulation of extracellular matrix organization.

FREM1 is identified as a candidate mediator of anlotinib resistance in NSCLC via regulation of ECM remodeling through silencing FREM1 potently reversed the anlotinib-induced suppression of key ECM components.

Yi Dong, Jingjing Zhang, Yuyang Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.